(Press-News.org) Reston, VA (August 1, 2025)—New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
Summaries of the newly published research articles are provided below.
New Imaging Tool Targets Hidden Liver Tumors
Liver cancer is hard to monitor after treatment, but a new PET imaging agent may help. Scientists developed a radiotracer that targets CD24, a protein found on liver tumor cells. In lab tests, the tracer accurately detected CD24-positive tumors in mice, offering a potential breakthrough in liver cancer imaging.
Tumor Response Patterns Offer Clues to Prostate Cancer Outcomes
Researchers used PSMA PET/CT scans to track prostate cancer spread in patients receiving therapy. They found that tumors responding differently within the same patient—called interlesional progression—predicted shorter survival. This imaging approach may help identify patients less likely to benefit from treatment early in their care journey.
Imaging Heart Health in Friedreich Ataxia
Friedreich ataxia affects the heart and nervous system, but tracking its progression is challenging. Researchers tested a PET method using a compound that detects mitochondrial activity. In both mice and humans, heart scans revealed reduced activity linked to the disease, offering a promising way to monitor treatment and progression.
Visit the JNM website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed or follow us on LinkedIn.
###
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org.
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.
END
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025
2025-08-01
ELSE PRESS RELEASES FROM THIS DATE:
Young human blood serum factors show potential to rejuvenate skin through bone marrow
2025-08-01
“[…] we were able to reproduce systemic rejuvenating effects of circulating blood factors on the human skin, which have been so far only demonstrated in rodent heterochronic parabiosis studies.”
BUFFALO, NY — August 1, 2025 — A new research paper featured on the cover of Volume 17, Issue 7 of Aging (Aging-US) was published on July 25, 2025, titled “Systemic factors in young human serum influence in vitro responses of human skin and bone marrow-derived blood cells in a microphysiological co-culture system.”
The study, led by first author Johanna Ritter and corresponding ...
Large language models reshape the future of task planning
2025-08-01
A comprehensive survey published May 23 in Intelligent Computing, a Science Partner Journal maps out the role of large language models in task planning, underscoring the growing influence of artificial intelligence in complex decision-making tasks.
Traditionally reliant on expert systems and manual configuration, task planning is essential for organizing action sequences to achieve defined goals, and is now being redefined by the advanced reasoning capabilities of large language models. The survey offers a comprehensive synthesis of how these models are reshaping ...
Narrower coverage of MS drugs tied to higher relapse risk
2025-08-01
Medicare drug plans are increasingly excluding coverage of new specialty drugs that treat complex conditions like cancers and autoimmune diseases. New research from the USC Schaeffer Center shows how these barriers may come at a cost to patients’ health.
In a large study of Medicare beneficiaries with multiple sclerosis (MS), researchers found those in plans with broader coverage of MS treatments had significantly lower risk of developing new or worsening symptoms months later. The findings, published Aug. 1 in JAMA Network Open, suggest that plans with narrower coverage of MS treatments may be linked to worse health ...
Researchers harness AI-powered protein design to enhance T-cell based immunotherapies
2025-08-01
A new paper published today in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key driver in T-cell development and function. These so-called soluble Notch agonists can be broadly applied to optimize clinical T-cell production and advance immunotherapy development.
Notch signaling is central to many cellular differentiation processes and is essential in transforming human immune cells into T-cells that target ...
Smartphone engagement during school hours among US youths
2025-08-01
About The Study: This cross-sectional study found that when adolescents had their phones at school, they spent nearly an hour per school day on smartphones, with most of this time on social media. The results extend prior work indicating that smartphone use during instructional hours, especially social-specific use, is not trivial. These results also highlight developmental differences, with younger adolescents using smartphones and social media less than older adolescents.
Corresponding author: To contact the corresponding author, Scott H. Kollins, Ph.D., email scott@aura.com.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi: ...
Online reviews of health care facilities
2025-08-01
About The Study: In this cross-sectional analysis, negative patient experiences frequently centered on quality of communication and administrative issues. Negative feedback centered on unmet expectations, whereas positive reviews emphasized supportive staff interactions.
Corresponding author: To contact the corresponding author, Neil K.R. Sehgal, M.E., email neilsehgal99@gmail.com.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi: 10.1001/jamanetworkopen.2025.24505)
Editor’s Note: Please see the article for additional ...
MS may begin far earlier than previously thought
2025-08-01
The earliest warning signs of multiple sclerosis (MS) may emerge more than a decade before the first classical neurological symptoms occur, according to new research from the University of British Columbia.
Published today in JAMA Network Open, the study analyzed the health records of more than 12,000 people in British Columbia and found that those with MS began using healthcare services at elevated rates 15 years before their first MS symptoms appear.
The findings challenge long-held assumptions about when the disease truly begins, offering the most comprehensive ...
New AI tool learns to read medical images with far less data
2025-08-01
A new artificial intelligence (AI) tool could make it much easier—and cheaper—for doctors and researchers to train medical imaging software, even when only a small number of patient scans are available.
The AI tool improves upon a process called medical image segmentation, where every pixel in an image is labeled based on what it represents—cancerous or normal tissue, for example. This process is often performed by a highly trained expert, and deep learning has shown promise in automating this labor-intensive task.
The big challenge is that deep learning-based ...
Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025
2025-08-01
The University of Copenhagen is excited to announce XPRIZE Healthspan as Tier 5 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online.
ARDD has grown to become the largest and most important conference in longevity biotechnology. Each year, ARDD brings together a unique mix of academic luminaries, biotech innovators, investors, top pharmaceutical executives, physicians, and related health care professionals to discuss ...
Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025
2025-08-01
The University of Copenhagen is excited to announce Immortal Dragons as Tier 4 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online.
Immortal Dragons is a purpose-driven longevity fund headquartered in Singapore, supporting 15+ portfolio companies in longevity and radical life extension technologies. Immortal Dragons values impact rather than economic return, supporting moonshot longevity startups in radical life extension, key areas include: Wholebody replacement, ...